Arch Phys Med Rehabil
- MONAGHAN PG, Daugherty AM, Fritz NE
Establishing the Reliability of The Step Test Evaluation of Performance on Stairs
(STEPS) in Multiple Sclerosis.
Arch Phys Med Rehabil. 2024 Apr 6:S0003-9993(24)00909.
Can J Neurol Sci
- BALCOM EF, McCombe JA, Kate M, Vu K, et al
Geographical variation in medication and health resource use in multiple
sclerosis.
Can J Neurol Sci. 2024 Apr 11:1-21. doi: 10.1017/cjn.2024.
J Neurol
- STALTER J, Pars K, Witt K
Accelerated long-term forgetting reveals everyday memory deficits in early-stage
multiple sclerosis.
J Neurol. 2024 Apr 8. doi: 10.1007/s00415-024-12359.
Mult Scler
- KLISTORNER S, Barnett MH, Wang C, Parratt J, et al
Longitudinal enlargement of choroid plexus is associated with chronic lesion
expansion and neurodegeneration in RRMS patients.
Mult Scler. 2024;30.
- REEVES JA, Mohebbi M, Wicks T, Salman F, et al
Paramagnetic rim lesions predict greater long-term relapse rates and clinical
progression over 10 years.
Mult Scler. 2024;30.
- TUR C, Battiston M, Yiannakas MC, Collorone S, et al
What contributes to disability in progressive MS? A brain and cervical
cord-matched quantitative MRI study.
Mult Scler. 2024;30.
- 'T HART BA, van Luijn MM
EBV infection drives MS pathology: No.
Mult Scler. 2024;30.
- SCHNEIDER M, Kramer J, Banks A, Moses H, et al
New onset lymphopenia in patients with relapsing multiple sclerosis switching
from long-standing dimethyl fumarate treatment to diroximel fumarate: A case
series.
Mult Scler. 2024 Apr 11:13524585241242027. doi: 10.1177/13524585241242027.
- MOCCIA M, Terracciano D, Brescia Morra V, Castaldo G, et al
Neurofilament in clinical practice: Is the multiple sclerosis community ready?
Mult Scler. 2024 Apr 11:13524585241246536. doi: 10.1177/13524585241246536.
- ALOISI F, Salvetti M
EBV infection drives MS pathology: Yes.
Mult Scler. 2024;30.
- CORTESE M, Ascherio A
EBV infection drives MS pathology: Commentary.
Mult Scler. 2024;30.
Nat Med
- ARNOLD C
'Inverse vaccines' could treat autoimmune disease - from multiple sclerosis to
celiac disease.
Nat Med. 2024 Apr 10. doi: 10.1038/d41591-024-00024.
Nat Rev Neurol
- WOOD H
EBV-specific T cells in multiple sclerosis.
Nat Rev Neurol. 2024 Apr 10. doi: 10.1038/s41582-024-00959.
- WOOD H
BTK inhibitor falters in multiple sclerosis trials.
Nat Rev Neurol. 2024 Apr 10. doi: 10.1038/s41582-024-00958.
Neurol Clin Pract
- GRAHAM EL, Bove R, Costello K, Crayton H, et al
Practical Considerations for Managing Pregnancy in Patients With Multiple
Sclerosis: Dispelling the Myths.
Neurol Clin Pract. 2024;14:e200253.
Rev Neurol (Paris)
- LERAY E, Regaert C, Duguet E, Guillaume S, et al
Impact of multiple sclerosis on employment and income: Insights from a random
sample representative of private sector employees in France using longitudinal
administrative data.
Rev Neurol (Paris). 2024 Apr 5:S0035-3787(24)00479.
- FREEMAN SA, Zephir H
Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current
treatment strategy.
Rev Neurol (Paris). 2024 Apr 9:S0035-3787(24)00474.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016